Assessment of selegiline and trilostane combined therapy efficacy for canine pituitary-dependent hypercortisolism treatment: A pilot randomized clinical trial-Reference-Cited by-同舟云学术

Assessment of selegiline and trilostane combined therapy efficacy for canine pituitary-dependent hypercortisolism treatment: A pilot randomized clinical trial

Published:2022-12 Issue: Volume:150 Page:107-114
ISSN:0034-5288
Container-title:Research in Veterinary Science
language:en
Short-container-title:Research in Veterinary Science

Author:

de Carvalho Guilherme Luiz Carvalho,Meirelles Luana,da Silva Carolina Castilhos,Neto Waldemir Santiago,Furtado Priscila Viau,Machado Letícia,de Moura Martins Francisco Sávio,da Silva Mello Fabíola Peixoto,de Faria Valle Stella,Pöppl Álan Gomes

Publisher

Elsevier BV

Subject

General Veterinary

Reference54 articles.

1. Comparison of 2 doses for ACTH stimulation testing in dogs suspected of or treated for hyperadrenocorticism;Aldridge;J. Vet. Intern. Med.,2016

2. Pituitary-targeted medical therapy of Cushing’s disease;Alexandraki;Expert Opin. Investig. Drugs,2008

3. Diagnosis of spontaneous canine hyperadrenocorticism: 2012 ACVIM consensus statement (small animal);Behrend;J. Vet. Intern. Med.,2013

4. Diagnosis of spontaneous hyperadrenocorticism in dogs. Part 1: pathophysiology, aetiology, clinical and clinicopathological features;Bennaim;Vet. J.,2019

5. Comparison of adrenocorticotropic hormone stimulation test results started 2 versus 4 hours after trilostane administration in dogs with naturally occurring hyperadrenocorticism;Bonadio;J. Vet. Intern. Med.,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure-activity relationship and docking analysis of nature flavonoids as inhibitors of human and rat gonadal 3β-hydroxysteroid dehydrogenases for therapeutic purposes;The Journal of Steroid Biochemistry and Molecular Biology;2024-04

2. Curcumin analogues exert potent inhibition on human and rat gonadal 3β-hydroxysteroid dehydrogenases as potential therapeutic agents: structure-activity relationship and in silico docking;Journal of Enzyme Inhibition and Medicinal Chemistry;2023-05-15